Lecanemab: Promising Cure or Expensive Gamble?
The debate over lecanemab, one of the first Alzheimer’s drugs to slow cognitive decline, is heating up.
Western Canadian Reason Conference
Western Canadian Reason Conference
The debate over lecanemab, one of the first Alzheimer’s drugs to slow cognitive decline, is heating up.